Your browser doesn't support javascript.
loading
Translating in vivo metabolomic analysis of succinate dehydrogenase deficient tumours into clinical utility.
Casey, Ruth T; McLean, Mary A; Madhu, Basetti; Challis, Benjamin G; Ten Hoopen, Rogier; Roberts, Thomas; Clark, Graeme R; Pittfield, Deborah; Simpson, Helen L; Bulusu, Venkata R; Allinson, Kieran; Happerfield, Lisa; Park, Soo-Mi; Marker, Alison; Giger, Olivier; Maher, Eamonn R; Gallagher, Ferdia A.
Afiliación
  • Casey RT; Department of Medical Genetics, University of Cambridge and NIHR Cambridge Biomedical Research Centre and Cancer Research UK Cambridge Centre, CB2 OQQ, United Kingdom.
  • McLean MA; Department of Endocrinology, Cambridge University NHS Foundation Trust, Cambridge, CB2 OQQ, United Kingdom.
  • Madhu B; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
  • Challis BG; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
  • Ten Hoopen R; Department of Endocrinology, Cambridge University NHS Foundation Trust, Cambridge, CB2 OQQ, United Kingdom.
  • Roberts T; Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.
  • Clark GR; Haematology Oncology Diagnostic Service (HODS), Cambridge University NHS Foundation Trust, Cambridge, CB2 OQQ, United Kingdom.
  • Pittfield D; Department of Medical Genetics, University of Cambridge and NIHR Cambridge Biomedical Research Centre and Cancer Research UK Cambridge Centre, CB2 OQQ, United Kingdom.
  • Simpson HL; Department of Endocrinology, Cambridge University NHS Foundation Trust, Cambridge, CB2 OQQ, United Kingdom.
  • Bulusu VR; Department of Diabetes and Endocrinology, University College London Hospitals, NHS Foundation Trust, London, NW1 2PG UK.
  • Allinson K; Department of Medical Oncology, Cambridge University NHS Foundation Trust, Cambridge, CB2 OQQ, United Kingdom.
  • Happerfield L; Department of Histopathology Cambridge University NHS Foundation Trust and Cancer Research UK Cambridge Centre Cambridge, CB2 0QQ, United Kingdom.
  • Park SM; Department of Immunohistochemistry, Cambridge University NHS Foundation Trust, Cambridge, CB2 OQQ, United Kingdom.
  • Marker A; Department of Medical Genetics, University of Cambridge and NIHR Cambridge Biomedical Research Centre and Cancer Research UK Cambridge Centre, CB2 OQQ, United Kingdom.
  • Giger O; Department of Histopathology Cambridge University NHS Foundation Trust and Cancer Research UK Cambridge Centre Cambridge, CB2 0QQ, United Kingdom.
  • Maher ER; Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.
  • Gallagher FA; Department of Medical Genetics, University of Cambridge and NIHR Cambridge Biomedical Research Centre and Cancer Research UK Cambridge Centre, CB2 OQQ, United Kingdom.
JCO Precis Oncol ; 2: 1-12, 2018 Mar 29.
Article en En | MEDLINE | ID: mdl-30949620
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: JCO Precis Oncol Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: JCO Precis Oncol Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido